Medical Research News and Research

RSS

Researchers identify differences in immune response in asymptomatic versus severe COVID-19 cases

The largest study of its type in the UK has identified differences in the immune response to COVID-19, between people with no symptoms, compared to those suffering a more serious reaction to the virus.

21 Apr 2021

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

Using an ACTIV master protocol, the trial will focus on potential interventions for mild-to-moderate illness.

20 Apr 2021

Study finds modest growth in home care workforce compared with the increasing demand

Recent growth in the number of healthcare workers providing home care for Medicare patients is "small and inadequate" compared with the increasing demand in an aging America, a new study suggests.

20 Apr 2021

Report highlights the effectiveness of collaborative care model for patients with dementia

A new report from the National Academies of Sciences, Engineering, and Medicine (National Academies) details the state of dementia care and research in America and provides guidance on future research to make sure both patients and their families are having their needs met by the care they receive.

19 Apr 2021

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing.

19 Apr 2021

Past COVID-19 infection does not completely protect against reinfection in young people

Although antibodies induced by SARS-CoV-2 infection are largely protective, they do not completely protect against reinfection in young people, as evidenced through a longitudinal, prospective study of more than 3,000 young, healthy members of the US Marines Corps conducted by researchers at the Icahn School of Medicine at Mount Sinai and the Naval Medical Research Center, published April 15 in The Lancet Respiratory Medicine.

17 Apr 2021

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.

17 Apr 2021

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

SARS-CoV-2, the virus that causes COVID-19, likely does not directly infect the brain but can still inflict significant neurological damage, according to a new study from neuropathologists, neurologists, and neuroradiologists at Columbia University Vagelos College of Physicians and Surgeons.

17 Apr 2021

Study sheds light on how autism manifests in the brains of girls

New research has shed light on how autism-spectrum disorder (ASD) manifests in the brains of girls, prompting the scientists to warn that conclusions drawn from studies conducted primarily in boys should not be assumed to hold true for girls.

16 Apr 2021

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.

16 Apr 2021

Study reveals new genes that program stem cells to make dendritic cells

Using a new single-cell technique, WEHI researchers have uncovered a way to understand the programming behind how stem cells make particular cell types.

16 Apr 2021

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

A past COVID-19 infection does not completely protect against reinfection in young people, according to an observational study of more than 3,000 healthy members of the US Marines Corps most of whom were aged 18-20 years, published in The Lancet Respiratory Medicine journal.

16 Apr 2021

Obese or overweight patients at high risk for having worse COVID-19 outcomes

Patients who are overweight or obese have more severe COVID-19 and are highly likely to require invasive respiratory support, according to a new international study.

15 Apr 2021

Medical EdTech specialist, Continulus forms partnership with the Australian Sepsis Network

Continulus has formed a global partnership with the highly regarded Australian Sepsis Network (ASN).

From Continulus 15 Apr 2021

Study shows how alcohol may affect the brain, offers potential treatments for alcohol misuse

The slurred speech, poor coordination, and sedative effects of drinking too much alcohol may actually be caused by the breakdown of alcohol products produced in the brain, not in the liver as scientists currently think

15 Apr 2021

People who trust TV and Facebook for accurate news about COVID-19 are less knowledgeable

People who trust television and Facebook to provide them with accurate news about the coronavirus pandemic are less knowledgeable about COVID-19, according to a new study, which assessed people's knowledge of the virus in the earliest stages of the pandemic.

15 Apr 2021

NIAID establishes a network of research sites to study influenza outbreaks

he National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks.

15 Apr 2021

Study may lead to new treatment for incurable brain cancer in children

Research by Australian scientists could pave the way to a new treatment for a currently incurable brain cancer in children called Diffuse Intrinsic Pontine Glioma, or DIPG. Affecting about 20 children in Australia each year, DIPG is a devastating disease with an average survival time of just nine months after diagnosis.

15 Apr 2021

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Two new studies, published in The Lancet Infectious Diseases and The Lancet Public Health, found no evidence that people with the B.1.1.7. variant experience worse symptoms or a heightened risk of developing long COVID compared with those infected with a different COVID-19 strain.

13 Apr 2021

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes COVID-19, has begun.

13 Apr 2021

Medical Research News and Research

Researchers identify differences in immune response in asymptomatic versus severe COVID-19 cases

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

Study finds modest growth in home care workforce compared with the increasing demand

Report highlights the effectiveness of collaborative care model for patients with dementia

New COVID-19 vaccine could provide protection against existing and future strains of coronaviruses

Past COVID-19 infection does not completely protect against reinfection in young people

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

SARS-CoV-2 does not directly infect the brain but can inflict neurological damage

Study sheds light on how autism manifests in the brains of girls

Study finds that not all patients with elevated eye pressure need treatment to prevent vision loss

Study reveals new genes that program stem cells to make dendritic cells

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

Obese or overweight patients at high risk for having worse COVID-19 outcomes

Medical EdTech specialist, Continulus forms partnership with the Australian Sepsis Network

Study shows how alcohol may affect the brain, offers potential treatments for alcohol misuse

People who trust TV and Facebook for accurate news about COVID-19 are less knowledgeable

NIAID establishes a network of research sites to study influenza outbreaks

Study may lead to new treatment for incurable brain cancer in children

Studies provide insights into characteristics and clinical effect of SARS-CoV-2 B.1.1.7 variant

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

A guide to advancing biotherapeutic research eBook

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News